2 completed. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Jan-Willem C Alffenaar: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Saliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR-TB in Tanzania Therapeutic drug monitoring (TDM) - MDR-TB | Not applicable | Completed | Jan-Willem C Alffenaar | 51 | 2019-09-24 | 2020-10-30 |
| Pharmacologic Optimization of Voriconazole voriconazole, voriconazole (dosing according to the SPC) - Invasive Fungal Infection, Hematological Malignancy | Phase 3 | Completed | Jan-Willem C Alffenaar | 189 | 2009-04-01 | 2017-01-12 |
Hematologic Neoplasms (1) · Invasive Fungal Infections (1) · Tuberculosis, Multidrug-Resistant (1)
Drug Monitoring (1) · Voriconazole (1)
Netherlands (1) · Tanzania (1)
J GW Kosterink, PharmD, PhD (1) · J WC Alffenaar, PharmD PhD (1) · Stellah Mpagama, PhD (1)